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Abstract
Background: Radical nephrectomy for renal cell carcinoma (RCC) is a risk factor for the development of chronic
kidney disease (CKD), and the possibility of postoperative deterioration of renal function must be considered before
surgery. We investigated the contribution of the aortic calcification index (ACI) to the prediction of deterioration of
renal function in patients undergoing radical nephrectomy.
Methods: Between January 1995 and December 2012, we performed 511 consecutive radical nephrectomies for
patients with RCC. We retrospectively studied data from 109 patients who had regular postoperative follow-up of
renal function for at least five years. The patients were divided into non-CKD and pre-CKD based on a preoperative
estimated glomerular filtration rate (eGFR) of ≥60 mL/min/1.73 m2 or <60 mL/min/1.73 m2, respectively. The ACI
was quantitatively measured by abdominal computed tomography before surgery. The patients in each group were
stratified between low and high ACIs. Variables such as age, sex, comorbidities, and pre- and postoperative renal
function were compared between patients with a low or high ACI in each group. Renal function deterioration-free
interval rates were evaluated by Kaplan-Meier analysis. Factors independently associated with deterioration of renal
function were determined using multivariate analysis.
Results: The median age, preoperative eGFR, and ACI in this cohort were 65 years, 68 mL/min/1.73 m2, and 8.3%,
respectively. Higher ACI (≥8.3%) was significantly associated with eGFR decline in both non-CKD and pre-CKD
groups. Renal function deterioration-free interval rates were significantly lower in the ACI-high than ACI-low strata
in both of the non-CKD and pre-CKD groups. Multivariate analysis showed that higher ACI was an independent risk
factor for deterioration of renal function at 5 years after radical nephrectomy.
Conclusions: Aortic calcification burden is a potential predictor of deterioration of renal function after radical
nephrectomy.
Trial registration: This study was registered as a clinical trial: UMIN000023577
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Background
Various studies have shown that radical nephrectomy for
renal cell carcinoma (RCC) is an independent risk factor
for the development of chronic kidney disease (CKD) [1, 2].
A radical nephrectomy remains the standard treatment for
patients, depending on factors such as tumor size, tumor
location, and comorbidities, nevertheless CKD increases
the risk of cardiovascular events and overall mortality [3].
Although it is suggested that CKD as a consequence of
surgery (such as nephrectomy) may be associated with a
relatively lower risk of progression and mortality than CKD
attributed to medical disorders (such as hypertension, type
2 diabetes, and/or cardiovascular disease) [4, 5], any CKD is
associated with an increased risk of cardiovascular events
and all-cause mortality in large, population based studies
[6–8]. Therefore, when discussing the therapeutic option of
radical nephrectomy, it is essential to estimate the risk of
postoperative deterioration of renal function. Potential
factors associated with severe postoperative renal im-
pairment have been reported, such as old age, preex-
isting stage 3 CKD, hypertension, type 2 diabetes, and
cardiovascular disease [1–3].
Aortic calcification is one of the sequelae of aortic de-
generation and has recently been considered a major
complication and independent risk factor for coronary
artery disease, heart failure, and stroke [9, 10]. Several
studies have addressed the clinical importance of arterial
calcification in patients at high risk for cardiovascular
disease; however, only a few studies have demonstrated
the impact of arterial calcification on renal function
[11–13]. In addition, the clinical relevance of the aortic
calcification index (ACI) with regard to postoperative
renal function outcome in patients undergoing radical
nephrectomy has not been well studied. Therefore, we
hypothesized that preexisting aortic calcification may
play a crucial role in the deterioration of renal function
after radical nephrectomy and investigated the contribu-
tion of the ACI in predicting postoperative renal func-
tion in such patients. This study was registered as a
clinical trial: UMIN000023577 (http://rctportal.niph.go.jp/
en/detail?trial_id=UMIN000023577).
Methods
Patient selection and variables evaluated
Between January 1995 and December 2012, we per-
formed 511 consecutive radical nephrectomies in pa-
tients with RCC. Of those, we excluded 95 patients who
deceased within five years, 165 patients without baseline
abdominal computed tomography (CT) prior to radical
nephrectomy, and 142 patients without postoperative
regular assessment of renal function for five years
after the surgery. The remaining 109 patients were in-
cluded in the present study. Blood tests including
renal function were routinely performed at least once
a year after radical nephrectomy. The estimated glom-
erular filtration rate (eGFR) was calculated using the
Modification of Diet in Renal Disease equation for
Japanese patients [14].
The patients were divided in two groups depending on
the preoperative eGFR, a non-CKD group with an eGFR
of ≥60 mL/min/1.73 m2 and a pre-CKD group with an
eGFR <60 mL/min/1.73 m2.
Using abdominal CT images (TSX-301B, Toshiba
Medical Systems Corp., Ohtawara, Japan, or CT750HD,
GE Healthcare Japan, Tokyo, Japan), the ACI was quan-
titatively measured by scanning 10 slices of the aorta at
5-mm intervals above the bifurcation of the common
iliac arteries as previously described [15]. Intimal calcifi-
cation was scored in each of 12 radial sectors of each
slice and reported as a percentage. For example, if 5 of
12 sectors were calcified in section 1, it was scored as 5/
12 = 41.7% (Fig. 1). The ACI (%) was calculated as the
average intimal calcification values of sections 1–10. ACI
measurement was performed by an investigator who was
blind to patients’ clinical parameters.
The patients in each group were stratified depending
on whether their ACIs were higher or lower than 8.3%,
based on the median value of ACI in this cohort. Vari-
ables including age; sex; history of hypertension, type 2
diabetes, or cardiovascular disease; clinicopathologic
data on the renal cancer; and renal function before and
Fig. 1 Patient selection and measurement of aortic calcification index
(ACI). Aortic calcification was quantitatively measured using preoperative
abdominal computed tomography images, evaluating 10 slices scanned
at 5-mm intervals above the abdominal aortic bifurcation. Each slice was
divided in 12 sectors and the numbers of sectors with calcification were
counted. The ACI was calculated by averaging the percentage of
calcium-positive sectors in each slice
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for 5 years after surgery were compared between patients
with low and high ACI in each group. Hypertension was
defined as taking any antihypertensive medications or pre-
operative systolic and diastolic blood pressure measure-
ments of >140 and >90 mmHg. Diabetes was defined a
history of type 2 diabetes or meeting the relevant diagnos-
tic criteria and requiring glycemic control. Cardiovascular
disease was defined as a positive history of cardiac surgery,
angina, myocardial infarction, or stroke or taking any
cardiotonic agents or coronary vasodilators.
The interval until the progression of CKD was measured
from 3 months after surgery until the eGFR decreased in
the non-CKD group to <60 ml/min/1.73 m2 (defined as
CKD3-free interval) or in the pre-CKD group to <45 ml/
min/1.73 m2 (defined as CKD3B-free interval).
Statistical analysis
Statistical analysis was performed using SPSS v. 22.0
(IBM Corporation, Armonk, NY, USA) and GraphPad
Prism v. 5.03 (GraphPad Software, San Diego, CA,
USA). Categorical variables were reported as percentages
and compared using Fisher’s exact test. Quantitative data
were expressed as medians with quartiles 1 and 3 (Q1, Q3).
Differences between the groups were compared using a t
test for normally distributed data or Mann—Whitney U
test for data with a non-normal distribution. Probability (P)
values of <0.05 were considered statistically significant.
Renal function deterioration-free intervals were evaluated
by Kaplan-Meier analysis. Independent factors associated
with the renal function deterioration-free interval were
identified by multivariate analysis using a Cox regression
model. Hazard ratios (HR) with 95% confidence intervals
(95% CI) were calculated after adjusting for potential con-
founders. Multivariate logistic regression analysis was per-
formed to identify significant risk factors for eGFR loss
>30% after radical nephrectomy at 5 years. Odds ratios
(OR) with 95% CI were calculated after adjusting for poten-
tial confounders. Liner regression analysis was performed
to develop a 5-year eGFR prediction formula, and correl-
ation was analyzed using Spearman’s correlation coefficient.
Results
Table 1 summarizes patients’ characteristics. The median
age, preoperative eGFR, and ACI in this cohort were
65 years, 68 mL/min/1.73 m2, and 8.3%, respectively.
The median ACI value of 8.3% was used as a cut-off be-
tween low and high ACI. Although there were statisti-
cally significant differences in ages between the low and
high ACI strata in the non-CKD and pre-CKD groups,
sex, renal function, comorbidities, and tumor stage did
not differ significantly (Table 1). In the non-CKD group,
longitudinal evaluation of eGFR revealed that the post-
operative median eGFR at 5 years in patients with low
and high ACI were 58 and 50 ml/min/1.73 m2, respect-
ively (P = 0.0061). It also showed significantly poorer
renal function in patients with a high than a low ACI in
Table 1 Comparison of clinical and pathological patient’s characteristics between low (<8.3%) and high (≥8.3%) ACI
non-CKD pre-CKD
low ACI high ACI P value low ACI high ACI P value
n 40 36 13 20
Age, years 57 (44–63) 67 (62–75) <0.001 62 (53–71) 76 (74–79) <0.001
Sex (Male) 26 (65%) 26 (72%) 0.499 9 (69%) 13 (65%) 1.000
Comorbidities
Hypertension 9 (23%) 11 (31%) 0.426 1 (8%) 9 (45%) 0.050
Diabetes 3 (8%) 7 (19%) 0.177 1 (8%) 3 (15%) 1.000
Cardiovascular disease 2 (5%) 2 (6%) 1.000 0 (0%) 1 (5%) 1.000
Preoperative eGFR 77 (68–87) 74 (67–84) 0.202 50 (42–54) 42 (33–55) 0.152
ACI (%) 0.8 (0.0–5.8) 18 (14–27) <0.001 0.8 (0.0–3.3) 18 (16–44) <0.001
Tumor stage
T1/2/3/4 25/6/7/2 23/3/10/0 0.394 7/4/2/0 13/3/3/1 0.810
Pathological subtype 0.277 1.000
Clear cell 35 (88%) 35 (97%) 12 (92%) 18 (90%)
Papillary 1 (2.5%) 1 (3%) 1 (8%) 1 (5%)
Chromophobe 1 (2.5%) 0 (0%) 0 (0%) 1 (5%)
Others 3 (7.5%) 0 (0%) 0 (0%) 0 (0%)
Distant metastasis 6 (15%) 3 (8%) 0.494 2 (15%) 3 (15%) 1.000
Tumor recurrence 9 (23%) 5 (14%) 0.334 2 (15%) 2 (10%) 1.000
Median and interquartile range (Q1, Q3) was used for consecutive variables. ACI aortic calcification index, eGFR estimated glomerular filtration rate
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the non-CKD group (Fig. 2a). The decline ratio at 5 years
after radical nephrectomy was higher in patients with a
high (36%) than a low ACI (28%) (Fig. 2b). Similarly, the
postoperative median eGFR at five years in the pre-CKD
group was significantly poorer in those with a high ra-
ther than a low ACI (32 ml/min/1.73 m2 vs. 42 ml/min/
1.73 m2, respectively, P = 0.0058) (Fig. 2c). In the pre-
CKD group, the eGFR showed 28% reduction at 1 year
after radical nephrectomy in patients with a high ACI,
whereas it was 13% in low ACI (Fig. 2d).
In terms of the rates of decline in eGFR, significant
differences were observed in both groups between pa-
tients with low and high ACI (Fig. 3a, b). The median
rate of decline at 5 years was significantly higher in pa-
tients with a high (32%) versus low ACI (28%) in the
non-CKD group (P = 0.0430) (Fig. 3a). Similarly, patients
with high ACI in the pre-CKD group exhibited re-
markably higher rates of decline (27%) than did those
with low ACI (6%) at 5 years after radical nephrec-
tomy (P = 0.0446) (Fig. 3b).
In the non-CKD group, CKD stage 3-free interval was
significantly shorter in patients with high ACI than in
those with low ACI (P = 0.0025) (Fig. 4a). Five-year CKD
stage 3-free rates were 19.4% and 42.5% in patients with
high and low ACI, respectively. Similarly, in the pre-
CKD group, the CKD stage 3B-free intervals were sig-
nificantly shorter in patients with high than with low
ACI (P = 0.0037) (Fig. 4b) Five-year CKD stage 3-free
rates were 0% and 15.4% in patients with a high or low
ACI, respectively.
Multivariate Cox regression analysis revealed that age,
preoperative eGFR, and ACI were independent risk factors
for CKD progression (Table 2). Multivariate logistic re-
gression analysis revealed that age, preoperative eGFR,
and ACI were independent risk factors for eGFR loss
>30% at five years after radical nephrectomy (Table 3).
Based on the significant variables, we developed a formula
by linear regression analysis to predict eGFR at five years
after radical nephrectomy: Y (estimated 5-year eGFR)
= (0.351 x preoperative eGFR) + (−0.232 x age) + (−0.208 x
ACI) + 41.758. The correlation between actual eGFR and
predicted values were significant (P < 0.001, r2 = 0.4623)
(Fig. 5). The minimal data set of the present study is avail-
able in Additional file 1: Dataset S1.
Discussion
In the present study, we demonstrated that a higher bur-
den of aortic calcification was an independent risk factor
for deterioration of renal function in patients after radical
nephrectomy. In addition, the postoperative decline in
renal function was significantly worse in patients with a
high ACI regardless of their preoperative eGFR. Multivari-
ate analysis revealed that the association of ACI with de-
terioration of renal function was statistically significant.
Our findings suggest that a patient’s ACI may be useful in
predicting renal function after unilateral nephrectomy.
Because aortic calcification is one of the results of aortic
degeneration, we hypothesized that it might predict de-
terioration of renal function after unilateral nephrectomy.
Indeed, our previous study suggested that the burden of
aortic calcification has impact on poor postoperative
renal function in renal transplant patients [12], as
well as with persistent hypertension after unilateral
adrenalectomy in patients with aldosterone-producing
A B
C D
Fig. 2 Renal function compared in patients with low and high ACI in non-CKD and pre-CKD groups. Longitudinal evaluation of eGFR reveals
significantly poorer renal function in patients with a high than a low ACI in the non-CKD group (a) and in the pre-CKD group (c). The decline
ratios are higher in patients with high rather than low ACI in the non-CKD group (b) and in the pre-CKD group (d)
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adenomas [16]. Although the mechanisms by which
aortic calcification might influence glomerular micro-
capillary degeneration remain unclear, it is not hard
to anticipate that vascular damage occurs first and
more severely in small vessels such as afferent arteri-
oles and glomeruli.
Risk factors for aortic calcification include older age,
higher systolic blood pressure, smoking, increased oxida-
tive stress, dyslipidemia, the presence of diabetes and/or
cardiovascular disease, and CKD [17, 18]. However, as all
these factors are correlated with each other, the association
is confusing, similar to asking whether the chicken or the
egg comes first. The element that is common to all such
risk factors is chronic, low grade, systemic inflammation,
which has been defined as a metabolic syndrome [19]. A
recent large study revealed that aortic valve calcification in-
volves inflammatory, lipid, and mineral metabolism path-
ways [20]. In addition, inflammation and oxidative stress
have been linked to vascular calcification in patients with
CKD [18]. Therefore, chronic, low grade, systemic inflam-
mation may accelerate arterial degeneration, resulting in
arterial calcification and reduced renal reserve. Further
studies are necessary to address the detailed association
between aortic calcification, inflammation, oxidative
stress, and CKD.
Aortic calcification was once believed to be a sim-
ple passive process of aging. However, it is now rec-
ognized as a complex and highly regulated systemic
process that involves the activation of cellular signal-
ing pathways, genetic factors, and hormones. It had
been assumed to be irreversible, and no agents were
available to prevent it. However, a recent study re-
ported that policosanol has the potential to inhibit
vascular calcification [21]. Elseweidy et al. reported
that treating diabetic hyperlipidemic rats with polico-
sanol, omega-3 fatty acids, and atorvastatin for eight
weeks significantly increased high-density lipoprotein
cholesterol (HDL-C) and vitamin D, decreased the
number of aortic vacuoles, and inhibited the calcifica-
tion process. Of the agents used, policosanol induced
more remarkable reduction in the density and num-
ber of foam cells and improved intimal lesions of the
aorta more than atorvastatin. The key effects of poli-
cosanol are inhibition of inflammation, oxidative
stress, and calcium deposition, all of which are essen-
tial pathways in aortic calcification.
A B
Fig. 3 Rate of decline of eGFR over 5 years in non-CKD and pre-CKD groups. Waterfall plots show significant differences between patients with a
high or low ACI in the non-CKD group (a) and pre-CKD group (b). In the pre-CKD group, patients with a high ACI had greater rates of decline
(27%) than those with a low ACI (6%) at 5 years after radical nephrectomy
A B
Fig. 4 CKD stage progression-free interval after radical nephrectomy. The CKD stage progression-free interval rates are significantly lower in the
patients with high ACI after radical nephrectomy in the non-CKD group (a) and in the pre-CKD group (b). CKD stage progression is defined as
CKD stage 0–2 progressing to stage 3 in the non-CKD group and CKD stage 3A progressing to 3B in the pre-CKD group
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In the present study, we found that patients in the
pre-CKD group who had a higher ACI had a marked de-
crease in renal function (Fig. 2d). Because older patients
were included in this group, the result might reflect se-
lection bias. However, multivariate analysis showed that
preoperative eGFR and ACI were independent predic-
tors’ deterioration of renal function after controlling for
other patient variables. Therefore, our findings suggest
that patients with RCC who have both preoperative
CKD and a high ACI are at significant risk for severe de-
terioration in renal function after unilateral nephrectomy.
Although our observation needs further investigation, aor-
tic calcification appears to be a potential surrogate marker
for diminished renal reserve after unilateral nephrectomy.
Several limitations need to be acknowledged. First,
selection of RCC patients with renal function for
5 years is a main limitation of our study. The small
sample size and single-institution retrospective design
prevent definitive conclusions on the influence of aor-
tic calcification on postoperative renal function. The
fact that only one observer calculated the ACI param-
eter could be another limitation. Significant differ-
ences in ages between the low and high ACI stratified
groups in the non-CKD and pre-CKD groups are a
strong limitation that restricts the value of the find-
ings. We could not exclude the multiple collinearity
among variables including age, eGFR, Hypertension,
and ACI. Definition of hypertension is not suitable for de-
tection postoperative renal impairment. Whether our
findings are generalizable to non-Asian populations is also
unclear. In addition, we were unable to include in the
analysis certain other established risk factors for renal dys-
function, such as cigarette smoking, dyslipidemia, protein-
uria, blood pressure control, and medications.
Second, our study did not assess the influence of aortic
calcification on cardiovascular events or overall survival
after radical nephrectomy in patients with RCC. Because
CKD resulting from surgery may not increase mortality
as much as CKD that is secondary to medical conditions,
[5] the association between a decline in renal function
after radical nephrectomy and mortality is under debate.
Recent research suggests that survival is better with CKD
occurring after surgery rather than with other diseases,
particularly if the postoperative eGFR is greater than
45 ml/min/1.73 m2, whereas patients with preexisting
CKD are at risk of a significant decline in renal function
after surgery [8]. Therefore, further large-scale, long-term
studies are required to resolve these issues.
Despite these limitations, the strength of this study is
its novel finding of the association between aortic calcifi-
cation and deterioration renal function after radical
nephrectomy. Using a non-invasive modality of measuring
ACI, we were able to demonstrate an independent associ-
ation between aortic calcification and postoperative renal
Table 2 Multivariate Cox regression analysis for risk factors for stage 3 CKD (eGFR < 60 mL/min/1.73 m2) in non-CKD group, or stage
3B CKD (eGFR < 45 mL/min/1.73 m2) in pre-CKD group
Cox regression analyses Risk factor P value HR 95% CI
Age, years Continuous 0.224 1.01 0.99–1.04
Sex Male 0.520 0.85 0.53–1.38
Diabetes Positive 0.936 0.97 0.51–1.86
Cardiovascular disease Positive 0.542 1.35 0.52–3.51
ACI (%) Continuous 0.044 1.02 1.00–1.03
Metastatic disease Positive 0.053 0.47 0.22–1.01
Preoperative eGFR (ml/min/1.73 m2) Continuous <0.001 0.97 0.96–0.99
ACI aortic calcification index, CKD Chronic kidney disease, eGFR estimated glomerular filtration rate
Table 3 Multivariate logistic regression analyses for risk factors for loss of renal function greater than 30% at 5 years after nephrectomy
Logistic regression analysis Risk factor P value OR 95% CI
Age, years Continuous 0.137 1.03 0.99–1.08
Sex Male 0.714 1.20 0.46–3.14
Diabetes Positive 0.202 0.40 0.10–1.63
Cardiovascular disease Positive 0.735 1.36 0.23–8.19
ACI (%) Continuous 0.016 1.05 1.01–1.09
Metastatic disease Positive 0.763 0.81 0.21–3.18
Preoperative eGFR (ml/min/1.73 m2) Continuous <0.001 1.07 1.03–1.10
ACI aortic calcification index, CKD Chronic kidney disease, eGFR estimated glomerular filtration rate
Fukushi et al. BMC Urology  (2017) 17:13 Page 6 of 8
impairment. Our findings may assist in recognizing
patients who are at high risk of CKD after radical
nephrectomy, which will help to inform the preopera-
tive discussion of therapeutic options.
Conclusions
In conclusion, the aortic calcification burden is a poten-
tial predictor for postoperative renal impairment. It may
be useful to identify patients who are at high risk for
renal impairment after radical nephrectomy.
Additional file
Additional file 1: Dataset-S1, Simple data set. Simple data set is
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deviation) and median (interquartile range) age were 63 ± 13 and 65 (55–73)
years old, respectively. Median height (cm) and body weight (kg) were 161
(155–167) and 63 (54–72), respectively. (XLSX 32 kb)
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